• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺移植后肥胖与原发性移植物功能障碍:肺移植结局组肥胖研究。

Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.

机构信息

Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.

出版信息

Am J Respir Crit Care Med. 2011 Nov 1;184(9):1055-61. doi: 10.1164/rccm.201104-0728OC.

DOI:10.1164/rccm.201104-0728OC
PMID:21799077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3208644/
Abstract

RATIONALE

Obesity has been linked to acute lung injury and is a risk factor for early mortality after lung transplantation.

OBJECTIVES

To examine the associations of obesity and plasma adipokines with the risk of primary graft dysfunction after lung transplantation.

METHODS

We performed a prospective cohort study of 512 adult lung transplant recipients with chronic obstructive pulmonary disease or interstitial lung disease enrolled in the Lung Transplant Outcomes Group Study. In a nested case-control study, we measured plasma leptin, adiponectin, and resistin before lung transplantation and 6 and 24 hours after lung transplantation in 40 cases of primary graft dysfunction and 80 control subjects. Generalized linear mixed models and logistic regression were used to estimate risk ratios and odds ratios.

MEASUREMENTS AND MAIN RESULTS

Grade 3 primary graft dysfunction developed within 72 hours of transplantation in 29% participants. Obesity was associated with a twofold increased risk of primary graft dysfunction (adjusted risk ratio 2.1; 95% confidence interval, 1.7-2.6). The risk of primary graft dysfunction increased by 40% (confidence interval, 30–50%) for each 5 kg/m(2) increase in body mass index after accounting for center, diagnosis, cardiopulmonary bypass, and transplant procedure. Higher plasma leptin levels were associated with a greater risk of primary graft dysfunction (sex-adjusted P = 0.02). The associations of both obesity and leptin with primary graft dysfunction tended to be stronger among those who did not undergo cardiopulmonary bypass.

CONCLUSIONS

Obesity is an independent risk factor for primary graft dysfunction after lung transplantation.

摘要

背景

肥胖与急性肺损伤有关,是肺移植后早期死亡的一个危险因素。

目的

研究肥胖和血浆脂肪因子与肺移植后原发性移植物功能障碍的风险之间的相关性。

方法

我们对慢性阻塞性肺疾病或间质性肺疾病的 512 例成人肺移植受者进行了前瞻性队列研究,这些受者参加了肺移植结局研究组。在巢式病例对照研究中,我们在肺移植后 6 小时和 24 小时测量了 40 例原发性移植物功能障碍患者和 80 例对照者的血浆瘦素、脂联素和抵抗素。使用广义线性混合模型和逻辑回归来估计风险比和比值比。

测量和主要结果

29%的患者在移植后 72 小时内出现 3 级原发性移植物功能障碍。肥胖使原发性移植物功能障碍的风险增加两倍(调整风险比 2.1;95%置信区间,1.7-2.6)。在考虑中心、诊断、体外循环和移植程序后,体重指数每增加 5kg/m²,原发性移植物功能障碍的风险增加 40%(置信区间,30-50%)。较高的血浆瘦素水平与原发性移植物功能障碍的风险增加相关(性别调整 P = 0.02)。肥胖和瘦素与原发性移植物功能障碍的相关性在未行体外循环的患者中似乎更强。

结论

肥胖是肺移植后原发性移植物功能障碍的一个独立危险因素。

相似文献

1
Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.肺移植后肥胖与原发性移植物功能障碍:肺移植结局组肥胖研究。
Am J Respir Crit Care Med. 2011 Nov 1;184(9):1055-61. doi: 10.1164/rccm.201104-0728OC.
2
Obesity and primary graft dysfunction: weighing the evidence.肥胖与原发性移植物功能障碍:权衡证据
Am J Respir Crit Care Med. 2011 Nov 1;184(9):994-6. doi: 10.1164/rccm.201108-1431ED.
3
Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.PTX3 的变异与肺移植后原发性移植物功能障碍有关。
Am J Respir Crit Care Med. 2012 Sep 15;186(6):546-52. doi: 10.1164/rccm.201204-0692OC. Epub 2012 Jul 19.
4
Body composition and mortality after adult lung transplantation in the United States.美国成人肺移植后的身体组成与死亡率
Am J Respir Crit Care Med. 2014 Nov 1;190(9):1012-21. doi: 10.1164/rccm.201405-0973OC.
5
Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.肺动脉高压患者肺移植后原发性移植物功能障碍的临床危险因素和预后模型。
Ann Am Thorac Soc. 2017 Oct;14(10):1514-1522. doi: 10.1513/AnnalsATS.201610-810OC.
6
Clinical risk factors for primary graft dysfunction after lung transplantation.肺移植后原发性移植物功能障碍的临床危险因素。
Am J Respir Crit Care Med. 2013 Mar 1;187(5):527-34. doi: 10.1164/rccm.201210-1865OC. Epub 2013 Jan 10.
7
Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study.肺移植后脂肪组织定量和原发性移植物功能障碍:肺移植人体成分研究。
J Heart Lung Transplant. 2019 Dec;38(12):1246-1256. doi: 10.1016/j.healun.2019.08.013. Epub 2019 Aug 10.
8
Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.血浆单核细胞趋化蛋白-1 水平在 24 小时时是肺移植后原发性移植物功能障碍的生物标志物。
Transl Res. 2012 Dec;160(6):435-42. doi: 10.1016/j.trsl.2012.08.003. Epub 2012 Sep 16.
9
Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant.肺移植后原发性移植物功能障碍定义修订的定量证据。
Am J Respir Crit Care Med. 2018 Jan 15;197(2):235-243. doi: 10.1164/rccm.201706-1140OC.
10
Associations of Serum Adipokines With Subclinical Interstitial Lung Disease Among Community-Dwelling Adults: The Multi-Ethnic Study of Atherosclerosis (MESA).血清脂肪因子与社区成年人亚临床间质性肺病的相关性:动脉粥样硬化多民族研究(MESA)。
Chest. 2020 Mar;157(3):580-589. doi: 10.1016/j.chest.2019.10.011. Epub 2019 Oct 31.

引用本文的文献

1
Incidence of primary graft dysfunction and its associated risk factors after lung transplantation: a systematic review and meta-analysis.肺移植术后原发性移植物功能障碍的发生率及其相关危险因素:一项系统评价和荟萃分析。
Surg Today. 2025 Sep 17. doi: 10.1007/s00595-025-03129-4.
2
Synergistic Integration of Multimodal Metabolic and Bariatric Interventions Transforming Transplant Care.多模式代谢与减重干预的协同整合变革移植护理
J Clin Med. 2025 Aug 11;14(16):5669. doi: 10.3390/jcm14165669.
3
Tolerability and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists in Lung Transplant Recipients: A Single Center Report.胰高血糖素样肽-1受体激动剂在肺移植受者中的耐受性和有效性:一项单中心报告
Transplant Proc. 2025 Mar;57(2):342-347. doi: 10.1016/j.transproceed.2024.11.016. Epub 2024 Dec 7.
4
Mitigating the risk of inflammatory type primary graft dysfunction by applying an integrated approach to assess, modify and match risk factors in lung transplantation.通过采用综合方法评估、调整和匹配肺移植中的风险因素,降低炎症性原发性移植物功能障碍的风险。
Front Transplant. 2024 Aug 20;3:1422088. doi: 10.3389/frtra.2024.1422088. eCollection 2024.
5
Analysis of Primary Graft Dysfunction (PGD) Risk Factors in Lung Transplantation (LuTx) Patients.肺移植(LuTx)患者原发性移植肺功能障碍(PGD)危险因素分析
Clin Pract. 2024 Aug 15;14(4):1571-1583. doi: 10.3390/clinpract14040127.
6
Early serum biomarkers to characterise different phenotypes of primary graft dysfunction after lung transplantation: a systematic scoping review.用于表征肺移植后原发性移植功能障碍不同表型的早期血清生物标志物:一项系统的范围综述
ERJ Open Res. 2024 Aug 5;10(4). doi: 10.1183/23120541.00121-2024. eCollection 2024 Jul.
7
Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort Study.双侧肺移植后基线期肺移植功能障碍与死亡风险增加相关:一项多中心队列研究的结果
Transplant Direct. 2024 Jun 26;10(7):e1669. doi: 10.1097/TXD.0000000000001669. eCollection 2024 Jul.
8
Lung Donation and Transplant Recipient Outcomes at Independent vs Hospital-Based Donor Care Units.独立供肺者照护单位与医院附设供肺者照护单位对肺脏捐赠及移植受赠者预后之影响。
JAMA Netw Open. 2024 Jun 3;7(6):e2417107. doi: 10.1001/jamanetworkopen.2024.17107.
9
Impact of recipient and donor pretransplantation body mass index on early postosperative complications after lung transplantation.肺移植术后早期受体和供体移植前体重指数对术后并发症的影响。
BMC Pulm Med. 2024 Apr 3;24(1):161. doi: 10.1186/s12890-024-02977-z.
10
Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates.肺移植候选者原发性移植功能障碍预测算法的开发与验证
J Heart Lung Transplant. 2024 Apr;43(4):633-641. doi: 10.1016/j.healun.2023.11.019. Epub 2023 Dec 6.

本文引用的文献

1
Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.特发性肺纤维化患者行单肺或双肺移植对血浆表面活性蛋白 D 水平的影响。
Chest. 2011 Aug;140(2):489-496. doi: 10.1378/chest.10-2065. Epub 2011 Feb 24.
2
Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-γ.瘦素通过抑制过氧化物酶体增殖物激活受体-γ促进纤维增生性急性呼吸窘迫综合征。
Am J Respir Crit Care Med. 2011 Jun 1;183(11):1490-8. doi: 10.1164/rccm.201009-1409OC. Epub 2011 Feb 11.
3
Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.血浆克拉拉细胞分泌蛋白浓度升高与高级别原发性移植物功能障碍相关。
Am J Transplant. 2011 Mar;11(3):561-7. doi: 10.1111/j.1600-6143.2010.03431.x. Epub 2011 Feb 7.
4
Influence of body mass index on outcome of the mechanically ventilated patients.体重指数对机械通气患者预后的影响。
Thorax. 2011 Jan;66(1):66-73. doi: 10.1136/thx.2010.145086. Epub 2010 Oct 27.
5
Study designs for biobank-based epidemiologic research on chronic diseases.基于生物样本库的慢性病流行病学研究的研究设计。
Methods Mol Biol. 2011;675:165-78. doi: 10.1007/978-1-59745-423-0_6.
6
Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis.肺动脉高压升高是特发性肺纤维化肺移植后原发性移植物功能障碍的一个危险因素。
Chest. 2011 Apr;139(4):782-787. doi: 10.1378/chest.09-2806. Epub 2010 Sep 23.
7
Construct validity of the definition of primary graft dysfunction after lung transplantation.肺移植后原发性移植物功能障碍定义的构效关系。
J Heart Lung Transplant. 2010 Nov;29(11):1231-9. doi: 10.1016/j.healun.2010.05.013. Epub 2010 Jul 22.
8
The association between BMI and plasma cytokine levels in patients with acute lung injury.BMI 与急性肺损伤患者血浆细胞因子水平的相关性。
Chest. 2010 Sep;138(3):568-77. doi: 10.1378/chest.10-0014. Epub 2010 Apr 30.
9
Obesity and lung inflammation.肥胖与肺部炎症。
J Appl Physiol (1985). 2010 Mar;108(3):722-8. doi: 10.1152/japplphysiol.00781.2009. Epub 2009 Oct 29.
10
Body mass index is associated with the development of acute respiratory distress syndrome.体重指数与急性呼吸窘迫综合征的发生有关。
Thorax. 2010 Jan;65(1):44-50. doi: 10.1136/thx.2009.117572. Epub 2009 Sep 21.